Form 4 holding
10%+ Owner
NeuroBo Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 1,220,502
- Estimated value
- $3,820,171
- Report date
- 16 Nov 2022
- Price
- $3.13
- Ownership
- Indirect
GOLDMAN SACHS GROUP INC - 10%+ Owner at MetaVia Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- MTVA on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by GOLDMAN SACHS GROUP INC since 05 Sep 2025
Reported holdings for GOLDMAN SACHS GROUP INC in MetaVia Inc.
Transaction history for GOLDMAN SACHS GROUP INC in MetaVia Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.